Corventis, Inc., a developer of wireless cardiovascular solutions, has recently introduced a wireless system, called PiiX, to monitor the heart health of a patient. This non-invasive, wireless sensor boasts of having the potential ability of detecting heart failure in its early stage.
It has been estimated that more than two million people in the U.S. may be having atrial fibrillation, which is a type of cardiac arrhythmia that may be closely linked with a higher stroke risk. Cardiac arrhythmia is said to be capable of triggering chest pain and may even lead to fainting.
The inaugural product of Corventis, which is the AVIVO Mobile Patient Management System, is said to have gained FDA approval, following which it is commercially made available within the U.S. The platform technology of Corventis is stated to have been designed with the aim of keeping a check on the heart health of a patient. For this purpose they have been designed through the use of advanced computational algorithms, patient-friendly wearable sensors, comprehensive web-based infrastructure and global wireless capabilities.
Leslie Saxon, M.D., chief, division of cardiology, Keck School of Medicine at the University of Southern California, Los Angeles, says that, “The Corventis technology platform has the potential to transform arrhythmia monitoring for both patients at home and eventually, hospitalized patients. The freedom of movement and timely arrhythmia detection will create a comfortable environment for all patients. We’ve learned that networked devices that can provide nearly instantaneous diagnosis, treatment and reassurance to patients answer one of the greatest needs in medicine today.”
PiiX, the 15-centimeter wireless wearable sensor, permits cardiologists to constantly monitor the cardiovascular health of the patient. This sensor is said to be able to automatically accumulate physiological data, which is then wirelessly sent to Corventis for deeper analysis. The development of this wireless, non-invasive technology is stated to have hinted at the possibility of keeping a regular check on the patient.
President and CEO of Corventis, Ed Manicka, PhD, says that, “Our mission is to advance healthcare through the confluence of advanced sensor microelectronics, wireless and internet technologies, providing physicians unprecedented visibility into a patient’s health status and enabling individualized preventive care. We are very proud of our accomplishments to date, including filing more than 50 patents internationally, deploying our solutions around the globe, successful enrollments in our clinical program and receiving this FDA clearance for our technology. The elegant solution we have developed will serve as a platform for multiple future products designed to improve the way heart conditions are managed.”
It was further stated that by evaluating the physiological changes in a patient, cardiologists may be able to effectively and proactively control their patients who suffer from heart failure. This may in turn aid in reducing the patients chances of getting hospitalized again.